Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GetRelief Rx vs Harbor

GetRelief Rx
Graded #365

Lower grade

vs+13.399999999999999
Harbor
Graded #85

Higher grade

The verdict

Harbor takes it — 72/100 to 58.6/100.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarbor +32
42
74
Dose & formulationGetRelief Rx +14
78
64
Clinical oversightHarbor +19
70
89
Labs & monitoringHarbor +11
52
63
FulfillmentHarbor +23
58
81
Contract termsEven
47
47
GetRelief Rx · left barHarbor · right bar

The numbers

MetricGetRelief RxHarbor
WeighScore58.6/10072/100
GradeCC
Scorecard rank#365#85
Semaglutide$269/mo (9 mg dose, compounded oral)$99/mo (starting dose, compounded)
Tirzepatide$179/mo (16 mg dose, compounded oral)$149/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
GetRelief Rx

Graded #365 · C

Strengths

  • Compounded semaglutide and tirzepatide priced publicly — no login required to see costs
  • BBB accredited with an A rating (March 2026)
  • Free online assessment with no upfront consultation fee

Where it loses points

  • Sublingual drops only — no injectable; this delivery method wasn't studied in the STEP/SURMOUNT trials
  • Still sells compounded tirzepatide after the FDA ended compounding enforcement discretion in 2025
  • No LegitScript, PCAB, or NABP pharmacy certifications found
  • Prescriber credentials listed only as 'licensed clinicians' with no detail on degree type
Harbor

Graded #85 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard